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Abstract
IMPORTANCE It is unknownwhich deteriorating ward patients benefit from intensive care unit
(ICU) transfer.
OBJECTIVES To use an instrumental variable (IV) method that assesses heterogeneity and to
evaluate estimates of person-centered treatment effects of ICU transfer and 28-day hospital
mortality by age and illness severity.
DESIGN, SETTING, AND PARTICIPANTS An analysis of a prospective cohort study fromNovember
1, 2010, to December 31, 2011. The dates of this analysis were June 1, 2017, to June 30, 2018. The
setting was a multicenter study of 49 UK National Health Service hospitals. Participants were 9192
deteriorating ward patients assessed for ICU transfer (4596 matched pairs). The study matched on
baseline characteristics to strengthen the IV and to balance observed confounders between the
comparison groups.
EXPOSURES Transfer to the ICU or continued care on general wards.
MAINOUTCOMES ANDMEASURES Mortality at 28 days (primary outcome) and 90 days. To
address unobserved confounding, ICU bed availability was the IV for whether or not a patient was
transferred. The study used the IV approach to evaluate estimates of treatment effect of ICU transfer
andmortality according to age and physiological severity alone and in combination.
RESULTS Both comparison groups included 4596 patients. In the group assessed with “many” ICU
beds available (median, 7), 52.8% were male, and the mean (SD) age was 65.2 (17.7) years; in the
group assessed with “few” ICU beds available (median, 2), 53.3%weremale, and themean (SD) age
was 65.0 (17.3) years. The overall 28-day mortality estimates were 23.2% (2090 predicted deaths) if
all of thematched patients were transferred vs 28.1% (2534 predicted deaths) if none of thematched
patients were transferred, an estimated risk difference of −4.9% (95% CI, −26.4% to 16.6%). The
estimated effects of ICU transfer differed by age and by physiological severity according to the
National Early Warning Score (NEWS): the absolute risk differences in 28-daymortality after ICU
transfer ranged from 7.7% (95%CI, −5.5% to 21.0%) for ages 18 to 23 years to −5.0% (95%CI -26.5%
to 16.6%) for age 78 to 83 years and ranged from 3.7% (95% CI, −12.1% to 19.5%) for NEWS of 0 to
−25.4% (95% CI, −50.6% to −0.2%) for NEWS of 19. The absolute risk differences for elderly patients
(75 years) were −11.6% (95%CI, −39.0% to 15.8%) for thosewith high NEWS (>6), −4.8% (95%CI,
−30.5% to 20.9%) for those with moderate NEWS (5-6), and −1.0% (95% CI, −24.8% to 22.8%) for
those with low NEWS (<5). The corresponding estimates for subgroups of younger patients (<75
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Abstract (continued)
years) were −8.4% (95% CI, −31.0% to 14.1%), −2.1% (95% CI, −21.1% to 16.9%), and 1.4% (95% CI,
−14.5% to 17.4%).
CONCLUSIONS ANDRELEVANCE This study using a this person-centered IV approach found that
the benefits of ICU care may increase among patients at high levels of baseline physiological severity
across different age groups, especially among elderly patients.
JAMA Network Open. 2019;2(2):e187704. doi:10.1001/jamanetworkopen.2018.7704
Introduction
The proportion of intensive care unit (ICU) patients who are elderly is increasing.1 Intensive care unit
costs are 1%of the gross domestic product in the United States and are potentially unsustainable.2,3
Previous observational studies4-6 reported that ICU transfer was associated with increasedmortality
but relied on risk adjustment methods that did not address confounding by indication or recognize
potential heterogeneity in the effectiveness of ICU care according to the patient’s prognosis. There
are major practical and ethical challenges in undertaking randomized clinical trials to evaluate ICU
transfer for deteriorating ward patients. A recent cluster randomized clinical trial7 reported that a
program to increase ICU admissions for elderly patients did not reduce hospital mortality. These
findings may discourage ICU transfer for older patients8-10 or reinforce treatment limitations, despite
concerns that the conclusions of the randomized clinical trial7 did not apply to routine clinical
practice.2
Precision or personalizedmedicine aims to provide the right interventions for the right patients
at the right times, which can be initiated according to anymeasures of the individual patient’s
prognosis and is not restricted to his or her genetic or biomarker profile.11-13 In particular, the gains
from ICU transfer may depend on prognostic factors, such as age, which may modify the
effectiveness of ICU transfer alone, and in synergy with measures, such as the patient’s physiological
status.14,15 A major challenge in generating evidence to support clinical decisionmaking is that the
gains from ICU care may differ according to unmeasured characteristics, such as frailty, whichmay
also determine whether or not the patient is transferred to the ICU. Previous studies14,15 have not
recognized that the effectiveness of ICU care may differ according to unmeasured patient-
level factors.
A newmethod for fully examining heterogeneity that addresses confounding by indication
reports person-centered treatment (PeT) effects.16-18 This method uses insights about how clinicians
select interventions according to the anticipated health gain for each patient to provide individual-
level estimates of treatment effectiveness, which are then aggregated to subgroups of prime
interest.16-19We revisit a natural experiment that used ICU bed availability as an instrumental variable
(IV) for ICU transfer to estimate the effectiveness of transfer for a subsample of deteriorating ward
patients.20 In contrast to the previous study, which focused on transfer within 4 hours, we estimate
the effectiveness of ICU transfer per se for all patients assessed. We fully assess heterogeneity in the
effectiveness of ICU transfer according to observed and unobserved characteristics across all eligible
deteriorating ward patients. To our knowledge, this article is the first to recognize that the
effectiveness of ICU care may bemodified according to patient characteristics that are unmeasured
and those that are measured.17,20-22 We estimate the effectiveness of ICU transfer according to
patient age and illness severity alone and combined.
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Methods
Data Source, Participants, andDefinitions
This prospective cohort study was conducted fromNovember 1, 2010, to December 31, 2011. The
dates of this analysis were June 1, 2017, to June 30, 2018.We used data from the (SPOT)light study,20
a prospective cohort of deteriorating ward patients assessed for possible transfer to the ICU in 49
UK National Health Service hospitals. This study followed the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) reporting guideline.20,23 We excluded repeat visits,
readmissions, deaths during the assessment, admissions after surgery (when admissionmay be
protocolized), and patients with preexisting treatment limitations. Intensive care unit admission and
survival were defined by linkage to the Intensive Care National Audit & Research Centre (ICNARC) Case
Mix Programme database and the National Health Service Information Service, respectively. The study
was registered on the National Institute of Health Research research portfolio (No. 9139) and with
ClinicalTrials.gov (NCT0101099813). Ethical approval was provided by the National Health Service
National Research Ethics Committee (Cambridgeshire 3) on September 2, 2010, for study protocol
version 1.1. Consent was not obtained, but permission to process patient data was approved by the
National Information Governance Board Ethics & Confidentiality Committee. The full study protocol
is available on the ICNARCwebsite.24
The treatment variable was transfer from award to the ICU, and the primary outcomewas
mortality up to 28 days after ICU assessment. The IV was ICU bed availability, defined as the sum of
physically empty ICU beds plus those with ICU patients ready for discharge.20,21,25,26 This measure
has been previously used as an IV for patient admission or transfer.20,21,25,26 Following these studies,
we assumed that spare ICU capacity encouraged transfer but did not otherwise affect themortality
of patients assessed.
Baseline covariates were all recorded by the bedside clinician at assessment for transfer and
included age, diagnosis of sepsis, periarrest (a clinical judgment of impending cardiorespiratory
arrest), and the physiological measures required to calculate the following 3 acute physiological
scores: the National Health Service National Early Warning Score (NEWS),27 the ICNARC physiology
score,28 and the Sequential Organ Failure Assessment (SOFA).29 The patient’s existing dependency
at ward assessment and recommended level of care after assessment were defined by UK Critical
Care Minimum Data Set levels of care, equivalent to general ward care (levels 0 and 1), high-
dependency care (level 2), and ICU (level 3).30 The data included indicators of low ICU capacity,
including whether ward assessment was during the weekend (Saturday or Sunday), outside of
regular hours (7 PM to 7 AM), or outside of the winter months (April through November).
Statistical Analysis
Near-FarMatching
We paired patients with similar baseline characteristics andmatched patients assessed when there
were “many” vs “few” ICU beds available, excludingmatched pairs with a difference of less than 3 ICU
beds available (eAppendix 1 in the Supplement).31 This near-far matching algorithm attempted to
ensure that measured confounders were balanced and the instrument (ICU bed availability) was
strong (ie, predicted ICU transfer).32-35 To assess the quality of thematches, we reported covariate
balance according to standardizedmean differences.
We assessed whether the IV designmet the essential criteria for validity. First, we calculated the
partial F statistic to indicate IV strength36 and found that the number of available beds was highly
correlated with ICU transfer (F statistic, 71). Second, we found that themeasured baseline risk factors
were balanced according to the number of available ICU beds (eFigure 1 in the Supplement).
Approach to Estimating PeT Effects Using the IVDesign
We estimated average PeT effects to fully account for heterogeneity and confounding (eAppendices
2, 3, and 4 in the Supplement).17-19,37,38 This IV approach recognizes that the transfer decision reflects
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unmeasured andmeasured patient and contextual factors. We identified “marginal” patients for
whom the physician was in equipoise about the transfer decision according to their measured (eg,
ICU beds available and physiological score) and unmeasured (eg, frailty) characteristics (eFigure 2 in
the Supplement). For these patients, a small change (or nudge) in the number of ICU beds available
(the IV) “tips the balance” for the decision to transfer the patient to the ICU but does not change the
distribution of his or her risk factors. Comparing outcomes for patients defined according to small
differences in the ICU beds available provides an estimate of the effect of ICU transfer for similar
patients. By repeating this contrast across different numbers of beds available (the IV), we estimate
treatment effects for sets of marginal patients with different combinations of confounders (eg, age
and NEWS). For each individual, a PeT effect is obtained by averaging the treatment effects for those
marginal patients who share the same observed and unobserved characteristics according to their
observed treatment choice. The PeT effects can be averaged over any sample characteristics to form
a subgroup-level mean effect.
For illustration, Figure 1 shows 3 patients (P, Q, and R) assessed for ICU transfer. In making the
transfer decision, the physician considers each patient’s expected outcome, acknowledging the ICU
bed capacity. Only some of the information the physician uses tomake this decision ismeasured and
available for the study (eg, age and NEWS); other confounders (eg, frailty) are unavailable. Here,
patient Q has a low propensity for transfer according to unobserved characteristics and is not
transferred, whereas patient R has a high overall propensity for transfer and is transferred. With just
2 beds available (Figure 1A), patient P is defined as marginal in that the physician is indifferent about
transferring the patient, who remains on the general ward.
With 3 ICU beds available (Figure 1B), the physician is nudged to recommend transfer for patient
P′. We use this information about the decision to transfer to infer that, for patients P and P′, the
observed and unobserved confounders must exactly balance. We use this insight to derive the
distributions of unobservable characteristics and contrast outcomes between sets of marginal
patients who are nudged toward (like patient P′) or away (like patient P) from ICU transfer by the
Figure 1. Essence of the Person-Centered Treatment Approach
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A patient’s propensity for transfer is gauged according
to observed and unobserved characteristics. Three
patients (P, Q, and R) share the same propensity
according to observed factors. However, the
propensity for intensive care unit (ICU) transfer
according to unobserved characteristics is low for
patient Q, balanced for patient P, and high for patient
R. An additional bed only affects the decision to
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marginal in that the propensity to transfer according to
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propensity due to observed characteristics. For this
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accounting for observed and unobserved
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number of available beds. By contrasting outcomes for alternative sets of marginal patients
according to different levels of bed availability, we estimate PeT effects for each patient while
accounting for unobserved confounding and heterogeneity. We average these individual PeT effects
for each patient across observed confounders of interest to derive minimally biased estimates of
heterogeneity in the effectiveness of ICU transfer.
The person-level IV approach was implemented as follows. First, we estimated each patient’s
propensity for ICU transfer according to his or her observed characteristics and the number of
available ICU beds. Second, we used these estimates of propensity for ICU transfer vs the observed
transfer status to estimate each marginal patient’s “residual” propensity for transfer according to his
or her unobserved characteristics (Figure 1C). Third, we used this estimated propensity for transfer
according to unobserved factors to allow for unobserved confounding when predicting outcomes
after ICU transfer vs general ward care (eAppendix 5 in the Supplement).
The PeT effect was defined for each patient in thematched data as the difference in his or her
predicted 28-day mortality with vs without ICU transfer. These person-level estimated treatment
effects were aggregated to report the stimated effects of ICU transfer over the whole matched
sample and for each prespecified subgroup of interest (age, NEWS, ICNARC physiology score, and
SOFA score) and for each physiologymeasure combined with age. The effectiveness of ICU transfer
was reported for patients 75 years and older or younger than 75 years21 for low (<5), moderate (5 or
6), or high (>6) levels of baseline risk according to NEWS27 and for the secondary end point of 90-day
mortality. Because both the exposure and the outcomeswere binary, probit regressionmodels were
used to estimate the PeT effects. The effectiveness of ICU transfer was reported as the mean (95%
CI) differences in the absolute risk of death.
Finally, we developed a simple predictive model (logistic regression) to examine which baseline
characteristics predicted themagnitude of the estimated absolute risk difference in 28-daymortality
(eAppendix 6 in the Supplement). We defined themagnitude of clinical benefit as a 10% difference
in 28-day mortality.20 All standard errors were calculated with nonparametric bootstrapping and
allowed for clustering of individuals within hospitals, with inferences conditional on thematched
data. Data analyses were performed in R (version 3.4.3; R Foundation for Statistical Computing) and
in Stata (version 14.1; StataCorp LP).
Sensitivity Analyses
To test whether the findings were robust to alternative choices, we considered alternative statistical
models, including different functional forms (probit vs logit) for the treatment and outcome
equations, the inclusion vs exclusion of higher-order terms for continuous baseline measures, and
interaction terms between each physiology score. We contrasted these estimates with a traditional
IV approach, 2-stage least squares, which reports estimated effectiveness for a subpopulation of
deteriorating ward patients,22 and to a regression approach that assumes no unmeasured
confounders (eAppendix 7 in the Supplement).
Results
A total of 13 011 eligible patients were assessed for ICU transfer, of whom 4994 (38.4%) were
transferred. Before matching, the ICU-transferred patients were, on average, younger, more often
had a diagnosis of sepsis, and were more severely ill (higher NEWS, ICNARC physiology score, and
SOFA score) (eTable 1 in the Supplement).
Among deteriorating ward patients assessed for ICU transfer, the near-far matching algorithm
identified 4596 matched pairs. In the matched sample (N = 9192), 52.8% of the many (median, 7)
ICU beds groupweremale, and themean (SD) agewas 65.2 (17.7) years; 53.3% of the few (median, 2)
ICU beds group weremale, and themean (SD) age was 65.0 (17.3) years. Other baseline
characteristics were also well balanced between the comparison groups (Table 1) and similar for the
matched vs unmatched samples (eTable 2 in the Supplement).
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The overall 28-daymortality estimates were 23.2% (2090 predicted deaths) if all of the
matched patients were transferred vs 28.1% (2534 predicted deaths) if none of thematched patients
were transferred, an estimated risk difference of −4.9% (95% CI, −26.4% to 16.6%) (Table 2). The
2-stage least squares approach also showed a lower 28-daymortality after ICU transfer (eTable 3 in
the Supplement), whereas the regression and unadjusted approaches, which did not allow for
unobserved confounding, demonstrated that ICU transfer was associated with an increase in 28-day
mortality (Table 2).
Table 1. Baseline Characteristics AfterMatching for AdmissionsWithMany vs Few Intensive Care Unit (ICU)
Beds Available at Time of Assessment for ICU Transfer
Variable Many ICU Beds Few ICU Beds Standardized Difference
No. of admissions 4596 4596 NA
No. of ICU beds available
Mean (SD) 7.64 (2.67) 1.68 (1.13) 2.905
Median (range) 7 (5-19) 2 (0-3) NA
Transfer to ICU, No. (%) 1995 (43.4) 1521 (33.1) 0.213
Age, mean (SD), y 65.23 (17.68) 65.00 (17.35) 0.013
Male, No. (%) 2426 (52.8) 2448 (53.3) −0.010
Reported sepsis diagnosis, No. (%) 2868 (62.4) 2873 (62.5) −0.002
CCMDS level of care at visit, No. (%)
0 496 (10.8) 604 (13.1) −0.072
1 3247 (70.6) 3162 (68.8) 0.040
2 755 (16.4) 792 (17.2) −0.022
3 54 (1.2) 30 (0.7) 0.055
Missing 44 (1.0) 8 (0.2) 0.105
Periarrest, No. (%) 233 (5.1) 164 (3.6) 0.074
Acute physiological scores, mean (SD)
NEWSa 6.18 (3.12) 6.28 (3.05) −0.030
ICNARC physiology scoreb 15.07 (7.40) 15.23 (7.12) −0.021
SOFA scorec 3.14 (2.19) 3.16 (2.15) −0.011
NEWS risk class, No. (%)
None 117 (2.5) 128 (2.8) −0.015
Low 1244 (27.1) 1150 (25.0) 0.047
Medium 1287 (28.0) 1304 (28.4) −0.008
High 1948 (42.4) 2014 (43.8) −0.029
Time of admission, No. (%)
Weekend 1172 (25.5) 1059 (23.0) 0.057
Outside of regular hours 1549 (33.7) 1649 (35.9) −0.046
Winter 960 (20.9) 960 (20.9) −0.000
Abbreviations: CCMDS, Critical Care MinimumData
Set; ICNARC, Intensive Care National Audit & Research
Centre; NA, not applicable; NEWS, National Early
Warning Score; SOFA, Sequential Organ Failure
Assessment.
a The NEWS ranges from0 (least severe) to 20
(most severe).
b The ICNARC physiology score ranges from0 (least
severe) to 100 (most severe).
c The SOFA score ranges from0 (least severe) to 14
(most severe).
Table 2. Overall 28-DayMortality After Intensive Care Unit (ICU) vs GeneralWard Care for theMatched Sample
Estimator Sample Sizea
ICU Deaths,
No. (%)b
General Ward Deaths,
No. (%)b
Risk Difference,
% (95% CI)c
IV (PeT, Probit) 9015 2090 (23.2) 2534 (28.1) −4.9 (−26.4 to 16.6)
IV (PeT, Logit) 9015 2096 (23.2) 2539 (28.2) −4.9 (−24.4 to 16.6)
Regression 9192 2594 (28.2) 1914 (20.8) 7.4 (5.0 to 9.8)
Unadjusted 9192 2915 (31.7) 1715 (18.7) 13.1 (11.2 to 14.9)
Abbreviations: IV, instrumental variable; PeT, person-centered treatment.
a For eachmethod, themaximum sample size was 9192. Observations were excluded if there is not mass at any value
(rounded to 0.01) of the propensity score for both levels of exposure as recommended by Basu.18
b The number of predicted deaths is rounded to the nearest whole number.
c Normal-based 95% CI with standard error is calculated with the nonparametric bootstrap, allowing for clustering by
hospital. Difference in percentage of deaths is from the PeT instrumental variable analysis.
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The PeT estimated risk differences according to physiological severity varied from 3.7% (95%
CI, −12.1% to 19.5%) for NEWS of 0 to −25.4% (95% CI, −50.6% to −0.2%) for NEWS of 19, with a
similar pattern observed according to baseline ICNARC physiology score or SOFA score (Figure 2 and
eTable 4 in the Supplement). The estimated risk differences by age varied from 7.7% (95%CI, −5.5%
to 21.0%) for age 18 to 23 years to −5.0% (95% CI, -26.5% to 16.6%) for ages 72 to 77 years (Figure 2
and eTable 4 in the Supplement). The predicted risk difference after ICU transfer was −10.1% (95%
Figure 2. Estimated Person-Centered Treatment Effects of Intensive Care Unit Transfer vs GeneralWard CareWith 28-DayMortality
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Person-centered treatment effects by strata. Absolute risk reductions (95% CIs) are
shown. Heterogeneous effects are estimated for each individual using the person-
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(most severe). The Intensive Care National Audit & Research Centre (ICNARC) physiology
score ranges from0 (least severe) to 100 (most severe). The Sequential Organ Failure
Assessment (SOFA) score ranges from0 (least severe) to 14 (most severe).
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CI, −33.2% to 13.0%) for those whowere actually transferred and 3.3% (95%CI, −15.2% to 21.8%) for
those whowere not (eTable 4 and eFigure 3 in the Supplement).
The absolute risk differences in 28-daymortality after ICU transfer for elderly patients (75
years) were −11.6% (95% CI, −39.0% to 15.8%) for those with high NEWS (>6), −4.8% (95% CI,
−30.5% to 20.9%) for those with moderate NEWS (5-6), and −1.0% (95% CI, −24.8% to 22.8%) for
those with low NEWS (<5). The estimates for corresponding subgroups of younger patients (<75
years) were −8.4% (95% CI, −31.0% to 14.1%), −2.1% (95% CI, −21.1% to 16.9%), and 1.4% (95% CI,
−14.5% to 17.4%) (eTable 5 in the Supplement).
Figure 3 shows that the patients predicted to have reductions of greater than 10% in the
absolute risk of 28-daymortality were those with high NEWS (>7) at assessment, who were also 60
years and older. Those patients predicted to have risk reductions between 0% and 10%hadNEWS of
3 to 7 and were 50 years and older. The groups predicted to have higher 28-daymortality after ICU
transfer were younger patients (<60 years), who had lower NEWS (<4) at assessment (eFigure 4 in
the Supplement).
Baseline characteristics associated with absolute risk reductions in 28-daymortality after ICU
transfer of greater than 10%were assessed. These characteristics included age; male sex; higher
levels of care at assessment; periarrest; higher NEWS, ICNARC physiology score, and SOFA score; and
admissions during core working hours (Monday through Friday, 9 AM to 5 PM) and not in winter
(eTable 6 and eTable 7 in the Supplement).
The overall PeT results for 90-daymortality were similar (eTable 8 in the Supplement), and the
same pattern of heterogeneity was present; the patients predicted to benefit most from ICU transfer
were older and more severely ill at assessment (eTable 9 and eFigure 5 in the Supplement). The
supplementary analyses demonstrated that the results were robust to alternative ways of
implementing the PeT approach (eTable 10 and eTable 11 in the Supplement). The findings were
similar with the baseline ICNARC physiology score or SOFA score (eFigure 4 and eFigure 5 in the
Supplement), as well as if those patients who were transferred later (after 24 hours) or
recommended for ICU (level 3) care were excluded (eTable 12, eTable 13, eFigure 6, and eFigure 7 in
the Supplement).
Figure 3. Bubble Chart Showing Estimated Person-Centered Treatment Effects of Intensive Care Unit Transfer
vs GeneralWard Care on 28-DayMortality, by Age Category and NEWS
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Discussion
This person-centered IV approach addressed heterogeneity and confounding according to
unobserved factors and found that the benefits of ICU transfer increase with age and physiology
score. Patients with low physiology scores at assessment did not appear to benefit from ICU transfer.
The study findings help identify which patients benefit most from ICU transfer and can inform future
triage policies that aim to deliver additional clinical benefits within current ICU capacity. These
findings bring into question recommendations that rely on estimates of the average effectiveness of
ICU transfer; these estimates may either encourage unsustainable expansion of critical care20,21 or
restrict access for elderly patients irrespective of their physiological status.7
Our patient-centered approach suggests that age and physiological severity act in synergy to
predict the likely benefits and harms from ICU care for individual patients. The finding that the
benefits from ICU transfer were greater in those recommended for transfer suggests that physicians
were already personalizing their approach and triaging according to the likely gain for individual
patients (eFigure 3 in the Supplement). Our finding that ICU transfer was beneficial for patients with
higher physiological score at assessment extends previous observational studies20,21 of the
effectiveness of ICU transfer for patients that used a traditional IV design. The findings from these
previous studies only apply to a subsample of patients, whereas our person-level IV approach
provided overall estimates of the effect of ICU care that apply to patients assessed for ICU care more
generally.
One potential concern for the generalizability of the results is that, in the United Kingdom, the
low levels of bed availability may imply that the patients considered for admission are more severely
ill than in other countries. There are few international comparisons of severity of illness, but a
patient-level meta-analysis39 of early goal-directed therapy (PRISM investigators) reported that the
median Acute Physiology and Chronic Health Evaluation II physiology score at randomization was
only slightly higher in the United Kingdom (12; interquartile range, 8-17) compared with the United
States (10; interquartile range, 7-15). Moreover, we present estimates of the effectiveness of ICU care
disaggregated according to commonly usedmeasures of case severity to help inform clinical decision
making in different contexts.
Strengths and Limitations
The study has several strengths. First, this IV approach originally developed in the econometrics
literature17,18 was able to identify which types of patients benefitedmost from ICU transfer. Second,
the article extended the previously published study20 that used the same IV design by addressing
interpatient heterogeneity. Third, the study reports that themain findings are robust to a battery of
alternative assumptions, notably those underlying the IV approach.
This study has potential limitations. First, IV analyses are notoriously statistically inefficient,40
but the IV approach described herein demonstrated smaller standard errors around the absolute risk
differences compared with traditional IV methods. Second, any subgroup analysis raises a concern
about spurious claims of statistical significance. Therefore, we prespecified hypotheses about which
risk factors were anticipated to modify the effect of ICU transfer with mortality21 and exploited the
rich set of baseline measures available from the ICNARC Case Mix Programme database.
Nevertheless, further research to test the replication of these findings would be useful.41 Third, to
assist future clinical decisionmakers, we developed a risk prediction algorithm.While the algorithm
has face validity according to the variables that predictedmortality gains from ICU transfer of greater
than 10%, it warrants testing in other contexts before it could be considered for use in routine clinical
practice.
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Conclusions
To our knowledge, this is the first study to evaluate ICU transfer with an IVmethod that
simultaneously recognizes patient heterogeneity and addresses confounding by indication. The
gains from ICU transfer were greater for older patients and for patients at higher levels of
physiological severity at assessment. This approach can help improve clinical outcomes from limited
ICU capacity by informing decisions about triage for ICU care and can informmoves to personalize
clinical decisionmakingmore widely.
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